Zusammenfassung
Hintergrund
Die Borderline-Persönlichkeitsstörung (BPS) gilt als schwerwiegende psychische Störung mit hoher Belastung für Patienten, Familienmitglieder und das Gesundheitssystem. Die letzten Jahre brachten deutliche Fortschritte im Verständnis und in der Therapie der BPS, was zu einer früheren Diagnose und besseren Behandlungsergebnissen geführt hat.
Ziel der Arbeit
Der Artikel skizziert den aktuellen Wissensstand zu Epidemiologie, Diagnostik, Psychopathologie und Behandlung der BPS und zeigt offene Fragen auf.
Material und Methoden
Mittels eines narrativen Reviews auf Basis einer Literatursuche in den Datenbanken PubMed, PsycINFO und EMBASE werden die neuesten Entwicklungen zum Thema BPS für die Bereiche Diagnostik, Epidemiologie, Ätiologie und Therapie beleuchtet. Hierfür wurden, wo möglich, systematische Übersichtsarbeiten und Metaanalysen sowie evidenzbasierte Praxisleitlinien berücksichtigt.
Stand der Wissenschaft
Im Zentrum der BPS stehen Störungen der Emotionsregulation, des Selbstbildes und der zwischenmenschlichen Interaktion. Die Suizidraten liegen zwischen 2 und 5 %, die Lebenserwartung ist gegenüber der Normalpopulation deutlich verkürzt. Die Wirksamkeit differenzierter, störungsspezifischer Psychotherapie (insbesondere dialektisch-behaviorale Therapie) ist gut belegt. Die psychotherapeutische Versorgung im ambulanten Sektor, insbesondere im Bereich der Kinder- und Jugendpsychiatrie, ist noch immer ungenügend.
Perspektiven
Fragen zur Ätiopathologie, insbesondere genetische und postulierte neurobiologische Parameter, die für eine affektive Hypersensitivität determinieren, sind weitgehend offen. Nosologisch ist die Abgrenzung zur komorbiden posttraumatischen Belastungsstörung (PTBS) sicherlich ein wichtiges Thema, das auch therapeutische Konsequenzen hat.
Abstract
Background
Borderline personality disorder (BPS) is considered as a severe mental disorder with a high burden for patients, family members and the healthcare system. Recent years have brought significant advances in understanding and treating BP, leading to an earlier diagnosis and better treatment outcomes.
Objective
This article outlines the current state of knowledge on the epidemiology, diagnostics, psychopathology and treatment of BPD and identifies open questions.
Material and methods
Based on a literature search in the PubMed, PsycINFO and EMBASE databases, the latest developments in the topic of BPD for the areas of diagnostics, epidemiology, etiology and treatment are illuminated in a narrative review. Where possible systematic review articles, meta-analyses and evidence-based practice guidelines were also considered.
State of the science
At the core of BPS are disorders of emotion regulation, self-image, and interpersonal interaction. The suicide rates range from 2% to 5% and life expectancy is significantly shortened compared with the general population. The effectiveness of differentiated, disorder-specific psychotherapy (especially dialectic behavioral therapy, DBT) is well established. Psychotherapeutic care in the outpatient sector, especially in the field of pediatric and adolescent psychiatry, is still insufficient.
Perspectives
Questions about the etiopathology, especially genetic and postulated neurobiological parameters that determine affective hypersensitivity, are largely open. Nosologically, the differentiation from comorbid complex posttraumatic stress disorder (cPTSD) is certainly an important issue, which also has therapeutic consequences.
Literatur
American Psychiatric Association, American Psychiatric Association, DSM‑5 Task Force. (2013) Diagnostisches und statistisches Manual psychischer Störungen: DSM‑5. American Psychiatric Association, Washington, D.C.
Álvarez-Tomás I, Ruiz J, Guilera G, Bados A (2019) Long-term clinical and functional course of borderline personality disorder: a meta-analysis of prospective studies. Eur Psychiatry 56:75–83
Aguilar-Ortiz S, Salgado-Pineda P, Vega D et al (2020) Evidence for default mode network dysfunction in borderline personality disorder. Psychol Med 50:1746–1754
Barnicot K, Crawford M (2019) Dialectical behaviour therapy v. mentalisation-based therapy for borderline personality disorder. Psychol Med 49:2060–2068
Bohus M (2020) Borderline-Störungen. Fortschritte der Psychotherapie. Hogrefe, Göttingen (2. Vollständig revidierte Auflage)
Bohus M, Kleindienst N, Hahn C, Müller-Engelmann M, Ludäscher P, Steil R, Fydrich T, Kuehner C, Resick PA, Stiglmayr C, Schmahl C, Priebe K (2020) Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: a randomized clinical trial. Jama Psychiatry. https://doi.org/10.1001/jamapsychiatry.2020.2148
Bohus M, Dyer A, Priebe K, Krüger A, Kleindienst N, Schmahl C, Niedtfeld I, Steil R (2013) Dialectical behaviour therapy for posttraumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomized controlled trial. Psychother Psychosom 82(4):221–233
Bornovalova MA, Hicks BM, Iacono WG, McGue M (2009) Stability, change, and heritability of borderline personality disorder traits from adolescence to adulthood: a longitudinal twin study. Dev Psychopathol 21:1335–1353
Chanen A, Sharp C, Hoffman P (2017) Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry 16:215–216
Choi-Kain LW, Gunderson JG (2019) Applications of good psychiatric management for borderline personality disorder: a practical guide, 1. Aufl. Amer Psychiatric Assn Pub, Washington, D.C
Ellison WD, Rosenstein LK, Morgan TA, Zimmerman M (2018) Community and clinical epidemiology of borderline personality disorder. Psychiatr Clin North Am 41:561–573
Fornaro M, Orsolini L, Marini S et al (2016) The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. J Affect Disord 195:105–118
Harned MS, Chapman AL, Dexter-Mazza ET, Murray A, Comtois KA, Linehan MM (2008) Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. J Consult Clin Psychol 76(6):1068–1075 (Dec)
Jeung-Maarse H, Herpertz SC (2020) Neues zur Diagnostik und Therapie von Persönlichkeitsstörungen – Änderungen in ICD-11. Nervenarzt 9:863–871
Keefe JR, Kim TT, DeRubeis RJ, Streiner DL, Links PS, McMain SF (2020) Treatment selection in borderline personality disorder between dialectical behavior therapy and psychodynamic psychiatric management. Psychol Med 24:1–9. https://doi.org/10.1017/S0033291720000550
Kleindienst N, Bohus M, Ludäscher P et al (2008) Motives for nonsuicidal self-injury among women with borderline personality disorder. J Nerv Ment Dis 196:230–236
Langer G, Meerpohl JJ, Perleth M, Gartlehner G, Kaminski-Hartenthaler A, Schünemann H (2012) GRADE-Leitlinien: 1. Einführung – GRADE-Evidenzprofile und Summary-of-Findings-Tabellen. Z Evid Fortbild Qual Gesundhwes 106(5):357–368. https://doi.org/10.1016/j.zefq.2012.05.017
Liebke L, Koppe G, Bungert M, Thome J, Hauschild S, Defiebre N, Izurieta Hidalgo NA, Schmahl C, Bohus M, Lis S (2018) Difficulties with being socially accepted: an experimental study in borderline personality disorder. J Abnorm Psychol 127(7):670–668 (Oct)
Liebke L, Bungert M, Thome J, Hauschild S, Gescher DM, Schmahl C, Bohus M, Lis S (2017) Loneliness, social networks, and social functioning in borderline personality disorder. Personal Disord 8(4):349–356. https://doi.org/10.1037/per0000208
Michonski JD, Sharp C, Steinberg L, Zanarini MC (2013) An item response theory analysis of the DSM-IV borderline personality disorder criteria in a population-based sample of 11- to 12-year-old children. Personal Disord 4:15–22
NICE National Institut for Health and Care Excellence (2018) 2018 surveillance of personality disorders (NICE guidelines CG77 and CG78). Surveillance report. Published 19 July 2018. https://www.nice.org.uk/guidance/cg78/resources/2018-surveillance-of-personality-disorders-nice-guidelines-cg77-and-cg78-4906490080/chapter/Surveillance-decision?tab=evidence. Zugegriffen: 7. Juni 2021
Santangelo PS, Reinhard I, Koudela-Hamila S et al (2017) The temporal interplay of self-esteem instability and affective instability in borderline personality disorder patients’ everyday lives. J Abnorm Psychol 126:1057–1065
Schneider F, Erhart M, Hewer W, Loeffler LA, Jacobi F (2019) Mortality. https://doi.org/10.3238/arztebl.2019.0405
Schulze L, Schulze A, Renneberg B, Schmahl C, Niedtfeld I (2019) Neural correlates of affective disturbances: a comparative meta-analysis of negative affect processing in borderline personality disorder, major depressive disorder, and posttraumatic stress disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 4:220–232
Sharp C, Vanwoerden S, Wall K (2018) Adolescence as a sensitive period for the development of personality disorder. Psychiatr Clin North Am 41:669–683
Sharp C, Steinberg L, Temple J, Newlin E (2014) An 11-item measure to assess borderline traits in adolescents: refinement of the BPFSC using IRT. Personal Disord 5:70–78
Jørgensen MS, Storebø OJ, Stoffers-Winterling JM, Faltinsen E, Todorovac A, Simonsen E (2021) Psychological therapies for adolescents with borderline personality disorder (BPD) or BPD features—a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. PLoS ONE 16(1):e245331. https://doi.org/10.1371/journal.pone.0245331
Skoglund C, Tiger A, Rück C, Petrovic P, Asherson P, Hellner C, Mataix-Cols D, Kuja-Halkola R (2021) Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population. Mol Psychiatry 26(3):999–1008. https://doi.org/10.1038/s41380-019-0442-0
Stoffers-Winterling J, Storebø OJ, Lieb K (2020) Pharmacotherapy for borderline personality disorder: an update of published, unpublished and ongoing studies. Curr Psychiatry Rep 22(8):37. https://doi.org/10.1007/s11920-020-01164-1
Storebo OJ, Stoffers-Winterling JM, Vollm BA et al (2020) Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 2020:CD12955
Frankenburg F, Fitzmaurice G, Zanarini M (2019) Deaths by suicide and other causes among patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up. J Clin Psychiatry 80(1):18m12436
Tomko RL, Trull TJ, Wood PK, Sher KJ (2014) Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Personal Disord 28:734–750
Wertz J, Caspi A, Ambler A et al (2020) Borderline symptoms at age 12 signal risk for poor outcomes during the transition to adulthood: findings from a genetically sensitive longitudinal cohort study. J Am Acad Child Adolesc Psychiatry 59:1165–1177.e2
Winsper C, Marwaha S, Lereya ST, Thompson A, Eyden J, Singh SP (2015) Clinical and psychosocial outcomes of borderline personality disorder in childhood and adolescence: a systematic review. Psychol Med 45:2237–2251
Wong J, Bahji A, Khalid-Khan S (2020) Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Systematic Review and Meta-Analysis. Can J Psychiatry 65:5–15
Witt SH, Streit F, Jungkunz M et al (2017) Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry 7:e1155
World Health Organisation (2020) ICD-11 diagnostic guidelines: personality and related traits, prepublication draft. Weltgesundheitsorganisation, Genf
Zanarini MC, Frankenburg FR, Reich DB, Wedig MM, Conkey LC, Fitzmaurice GM (2015) The course of marriage/sustained cohabitation and parenthood among borderline patients followed prospectively for 16 years. J Personal Disord 29:62–70
Zimmermann J, Kerber A, Rek K, Hopwood CJ, Krueger RF (2019) A short but comprehensive review of research on the alternative DSM‑5 model for personality disorders. Curr Psychiatry Rep 21:92
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Stoffers-Winterling, A. Krause-Utz und K. Lieb geben an, dass keine finanzielle Interessenkonflikte bestehen. M. Bohus erhält Erlöse aus Büchern, Seminaren und Workshops zum Thema der Dialektisch Behavioralen Therapie, ist Vorstand des Deutschen Dachverbandes DBT und Mitinhaber der Arbeitsgemeinschaft Wissenschaftliche Psychotherapie Freiburg.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Stoffers-Winterling, J., Krause-Utz, A., Lieb, K. et al. Was wissen wir heute über die Borderline-Persönlichkeitsstörung? Aktuelles zu Ätiologie, Diagnostik und Therapie. Nervenarzt 92, 643–652 (2021). https://doi.org/10.1007/s00115-021-01140-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-021-01140-x